|
Quotes & Info
|
| NBY > SEC Filings for NBY > Form 8-K on 7-Jan-2009 | All Recent SEC Filings |
7-Jan-2009
Change in Directors or Principal Officers
NovaBay Pharmaceuticals Inc is reporting that effective at the close of business on December 31, 2008, John (Jack) James O'Reilly retired from his position as Senior Vice President for Corporate and Business Development. Mr. O'Reilly's decision to retire was the result of hearing loss that has been increasingly preventing him from playing a full role within the company.
|
|